Physician profile
Benjamin Pinto
NPI 1689244550
$1,371.85
in general payments reported to CMS, 2019-2025
11 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Prosthodontics provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $113 · 2023: $48.61 · 2024: $933 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941 · Travel and Lodging: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.70 |
| Travel and Lodging | $318.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $318.20 | 2024 | |
| Straumann USA LLC | $297.06 | 2024-2025 | |
| A-Dec, INC. | $269.59 | 2024 | |
| Dentsply Sirona INC | $247.30 | 2024 | Implant Dentistry, Atlantis, Cerec |
| Neoss, INC. | $112.95 | 2021 | |
| Nobel Biocare USA | $48.61 | 2023 | Nobelactive |
| Biohorizons Implant Systems INC. | $22.63 | 2024 | Biohorizons |
| Voco America INC. | $17.98 | 2024 | Admira Fusion X-Tra, Voco Profluorid Varnish, Meron Plus Qm |
| American Orthodontics Corporation | $15.01 | 2025 | Master Series, LP and Ifit Tubes, Empower-Metal |
| Ultradent Products INC | $11.74 | 2024 | |
| Align Technology, INC. | $10.78 | 2025 | Invisalign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Pinto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.